Showing results (41-50 of 100) with videos related to
Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1995
Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremiaJ H Schrank, J W Kelly, C K McAllisterBioorganic & Medicinal Chemistry|October 24, 1998
Discovering transthyretin amyloid fibril inhibitors by limited screeningP W Baures, S A Peterson, J W KellyThe Australasian Journal of Dermatology|January 1, 1991
Serum interleukin-2 receptor levels and cutaneous T-cell lymphomaS J Gilmore, E M Benson, J W KellyCancer|November 1, 1985
Regression in malignant melanoma. A histologic feature without independent prognostic significanceJ W Kelly, R W Sagebiel, M S BloisArchives of Internal Medicine|February 1, 1992
Serum angiotensin-converting enzyme level is elevated in patients with human immunodeficiency virus infectionD R Ouellette, J W Kelly, G T AndersBiochemistry|October 16, 1999
The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditionsH A Lashuel, C Wurth, L Woo, et al.Medical Group Management Journal|June 3, 1999
Provider resource planning. A study of methods in multispecialty groups and systemsM Hampton, J W Kelly, B L Morgan, et al.Biochemistry|August 19, 1997
Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriersZ Lai, J McCulloch, H A Lashuel, et al.Journal of Molecular Biology|April 15, 2000
Mapping the transition state of the WW domain beta-sheetJ C Crane, E K Koepf, J W Kelly, et al.Annals of Surgery|July 1, 1985
Thin level IV malignant melanoma. A subset in which level is the major prognostic indicatorJ W Kelly, R W Sagebiel, S Clyman, et al.Pageof 10